2403 SIDNEY STREET, PITTSBURGH, PA
Investor Presentation
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion, Material Contracts
Other Events
Reports Financial Results for the Second Quarter 2025 and Highlights Progress Across Clinical Programs
Shareholder votes
Philanthropic Donor Funds Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(4)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload